Clinical trial · Interventional
Clinical Pharmacists' Intervention on Pain Management in Cancer Patients
Impact of Clinical Pharmacist Intervention as a Part of the Multidisciplinary Team on Clinical Outcomes in Cancer Patients With Pain in Nepal: A Feasibility Pilot Randomized Controlled Trial (PharmCaP Trial)
NCT05021393CI-TRIAL-00075407PharmCaPcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to evaluate the impact of clinical pharmacist intervention as a part of a multidisciplinary team to improve clinical outcomes of cancer patients with pain in comparison to standard care.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Cancer Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Clinical Pharmacist Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention Group
- description
- The intervention group will receive the services from a clinical pharmacist and the existing standard care available in the medical oncology ward.
- interventionNames
- Other: Clinical Pharmacist Intervention
- type
- NO_INTERVENTION
- label
- Control Group
- description
- The standard care includes the current existing care provided to patients in the hospital. In addition, it includes all the available medical and non-medical services except the service provided by the clinical pharmacist.
Primary outcomes (1)
- measure
- Pain Intensity
- timeFrame
- 4 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients above 18 years old, diagnosed with cancer, and had self-reported cancer pain within a month prior to the study. 2. Patients be able to read and understand the Nepalese language or English language. 3. the patient is under standard analgesia treatments. 4. the patient was estimated to have over 2 months of survival time. 5. Access to a telephone or mobile phone or internet 6. The patients must understand the study process and evaluation, agree to participate in this trial, and sign the informed. Exclusion Criteria: 1. Patients who self-reported to have severe cognitive impairments. 2. Patients who are unable to complete pain assessment. 3. Participating in any other investigational therapies or other study protocols that may impact pain intensity are the primary outcomes of this study. 4. History of drug abuse, history of drug addiction, or severe alcoholism. 5. Opioid allergy. 6. Critically ill patients
References
Publications (2)
- BACKGROUNDShrestha S, Blebil AQ, Teoh SL, Sapkota S, Kc B, Paudyal V, Gan SH. Clinical pharmacists' intervention on pain management in cancer patients (PharmaCAP trial): study protocol for a randomized controlled trial. J Pharm Policy Pract. 2023 Jan 24;16(1):14. doi: 10.1186/s40545-022-00505-0. PMID 36694232
- DERIVEDShrestha S, Sapkota S, Teoh SL, Kc B, Paudyal V, Lee SWH, Gan SH. Clinical pharmacist interventions on pain management in cancer patients (PharmaCAP) in low resource settings: a multicenter feasibility-pilot randomized controlled trial. Support Care Cancer. 2024 Nov 27;32(12):828. doi: 10.1007/s00520-024-08989-z. PMID 39601933